-
Company Insights
NewBEAM Diagnostics Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our BEAM Diagnostics Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. BEAM Diagnostics Inc is a digital health company that specializes in the development of behavioral assessments. The company focuses on creating accurate evaluation tools, leveraging its deep expertise in behavioral economics. It is headquartered in Roanoke, Virginia, the US. GlobalData's Medical Devices company profile report, “BEAM Diagnostics Inc Pipeline Insight and Competitive Landscape, 2024" provides information about the company...
-
Innovation Ranking
Innovation Ranking – Beam Therapeutics Inc
Beam Therapeutics Inc (Beam Therapeutics) is a biotechnology company. The company develops precision genetic medicines to treat serious genetic diseases. It is investigating BEAM-101 targeting sickle cell disease and beta-thalassemia, BEAM-102 against sickle cell disease and BEAM-201 for the treatment of T-cell acute lymphoblastic leukemia. Beam Therapeutics is also evaluating therapies against acute myeloid leukemia, alpha 1 antitrypsin deficiency, glycogen storage disorder 1a and Stargardt disease. It utilizes the REPAIR system for A-to-I (adenosine to inosine) RNA (Ribonucleic acid) editing...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEAM-201 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEAM-201 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-201 in T-Cell Acute Lymphocytic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BEAM-101 in Beta Thalassaemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BEAM-101 in Beta Thalassaemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-101 in Beta Thalassaemia Drug Details: BEAM-101 is under development for the...
-
Product Insights
NewMRC Systems GmbH Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MRC Systems GmbH Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MRC Systems GmbH (MRC Systems) is a medical device company that offers medical, electronic and laser optical products. The company’s products include laser beam stabilization, MR compatible cameras, pinprick, cardioman, photoactivation and stereotactic systems. It offers laser beam stabilization systems for the real-time stabilization, alignment, positioning and adjustment of laser beams. MRC Systems’s cardionan systems are used to identify...
-
Sector Analysis
NewRadiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Radiosurgery Systems Market Report Overview The Radiosurgery Systems market size was valued at $618.8 million in 2023 and will grow at a CAGR of more than 3% during 2023-2033. Radiosurgery Systems utilize beams to deliver a focused dose of radiation to a targeted tumor. Radiosurgery Systems Market Outlook 2023-2023 ($ Million) Buy Full Report for More Insights on the Radiosurgery Systems Market Forecast Download a Free Sample Report The Radiosurgery Systems market research report identifies quantitative market trends within cardiovascular...
-
Product Insights
NewQuarterly Whiskey pricing trends in Australia
Empower your strategies with our Quarterly Whiskey pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Whiskey pricing trends in the United Kingdom
Empower your strategies with our Quarterly Whiskey pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GL-0034 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GL-0034 in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GL-0034 in Type 2 Diabetes Drug Details: GL-0034 is under...
-
Product Insights
NewComputed Tomography (CT) Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Computed Tomography (CT) is a powerful, non-destructive evaluation technique used for producing 2D and 3D cross-sectional image of an object from a flat X-ray image. Computed Tomography (CT) is used on patients with a high risk of colon cancer, or full-motion heart scans for patients with high risk of heart disease. It can also be used for image complex fractures, detect infarction, tumors, calcifications, hemorrhage and bone trauma and also acute and chronic changes in the lung parenchyma etc. The...